SENEXON-S
- Manufacturer
- H.J. Harkins Company, Inc. | RUGBY LABORATORIES, INC. | TIME-CAP LABS, INC
- Effective date
- 2011-12-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 22:30:28
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients (in each tablet)
Docusate sodium 50 mg
Sennosides 8.6 mg
OTC - ASK DOCTOR SECTION
ASK A DOCTOR BEFORE USE IF YOU HAVE A SUDDEN CHANGE IN BOWEL HABITS THAT LASTS OVER TWO WEEKS
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist berfore use if you are taking any other drug. Laxatives may affect how other drugs work.
WARNINGS SECTION
Do not use if your are taking mineral oil; for longer than one week; when abdominal pain, nausea or vomiting are present
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - PURPOSE SECTION
Uses: relieves occasional constipation; generally produces bowel movement in 6-12 hours.
OTC - QUESTIONS SECTION
call 1 800 645-2158 9 am - 5 pm Monday - Friday
OTC - STOP USE SECTION
Stop use and ask a doctor if: you have rectal bleeding; you fail to have a bowel movement after use of this product. These may indicate a serious condition.
INACTIVE INGREDIENT SECTION
Inactive ingredients
carnauba wax, colloidal silicon dioxide, croscarmellose sodium
D-C yellow #10 aluminum lake, dibasic calcium phosphate
dihydrate, FD-C yellow #6 aluminum lake, hypromellose,
magnesium stearate, microcrystalline cellulose, polyethylene
glycol, sodium benzoate, stearic acide, Titanium dioxide
OTC - WHEN USING SECTION
Directions take preferably at bedtime or as directed by a doctor
If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maxiumum dosage)
DOSAGE & ADMINISTRATION SECTION
Dosage and Administration
Adults and children 12 years and over - 2 tablets once a day - maximum dosage - 4 tablets twice a day
children 6 to under 12 years - 1 tablet once a day maximum dosage - 2 tablets twice a day
children 2 to under 6 years - 1/2 tablet once a day - maximum dosage- 1 tablet twice a day
children under 2 years - ask a doctor
INDICATIONS & USAGE SECTION
RELIEVES OCCASIONAL CONSTIPATION
GENERALLY PRODUCES BOWEL MOVEMENT IN 6-12 HOURS
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Enter section text here
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1248013 | Senexon-S 50 MG / 8.6 MG Oral Tablet | PSN | 2 |
| 998740 | sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet | PSN | 2 |
| 1248013 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S] | SBD | 2 |
| 998740 | docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SCD | 2 |
| 998740 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet | SY | 2 |
| 1248013 | DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S] | SY | 2 |
| 1248013 | Senexon-S (docusate sodium 50 MG / sennosides, USP 8.6 MG) Oral Tablet | SY | 2 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52959-675-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d5b6-f424-e053-dadaa90a57ce | f6e923e8-46e8-4287-bd62-5b954829cd73 |
| 52959-675-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d5b6-f424-e053-dadaa90a57ce | f6e923e8-46e8-4287-bd62-5b954829cd73 |
| 52959-675-08 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d5b6-f424-e053-dadaa90a57ce | f6e923e8-46e8-4287-bd62-5b954829cd73 |
| 52959-675-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d5b6-f424-e053-dadaa90a57ce | f6e923e8-46e8-4287-bd62-5b954829cd73 |
| 52959-675-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d5b6-f424-e053-dadaa90a57ce | f6e923e8-46e8-4287-bd62-5b954829cd73 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-675-00 | SENEXON-S | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 2 | |
| 52959-675-02 | SENEXON-S | 120 in 1 BOTTLE, PLASTIC | TABLET, COATED | 120 | 2 | |
| 52959-675-08 | SENEXON-S | 180 in 1 BOTTLE, PLASTIC | TABLET, COATED | 180 | 2 | |
| 52959-675-30 | SENEXON-S | 30 in 1 BOTTLE, PLASTIC | TABLET, COATED | 30 | 2 | |
| 52959-675-60 | SENEXON-S | 60 in 1 BOTTLE, PLASTIC | TABLET, COATED | 60 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52959-675-00 | EA - Each | 52959-675 | 9d585c77-9f1c-48ae-87fe-bc9c38bc5985 | 1 | 2012-07-24 |
| 52959-675-02 | EA - Each | 52959-675 | 910aae5c-3cba-41c5-aefa-a56c03f4562b | 1 | 2012-07-24 |
| 52959-675-08 | EA - Each | 52959-675 | e85449e5-15c3-438a-8c8d-beeee061dd03 | 1 | 2012-07-24 |
| 52959-675-30 | EA - Each | 52959-675 | 019b1af6-9251-4611-bfc8-27c629f5a08b | 1 | 2012-07-24 |
| 52959-675-60 | EA - Each | 52959-675 | ef13180d-db0d-48d4-babb-b11c54d938bc | 1 | 2012-07-24 |
| 0536-4086-01 | EA - Each | 0536-4086 | af38146a-a60f-4c1c-9038-38a930152ea6 | 1 | 2012-07-24 |
| 0536-4086-10 | EA - Each | 0536-4086 | eb55d6fe-9265-49bf-8f42-35b29c4f319f | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| docusate sodium | ACTIVE INGREDIENT | F05Q2T2JA0 | 2 | |
| sennosides a and b | ACTIVE INGREDIENT | 1B5FPI42EN | 2 | |
| docusate | ACTIVE MOIETY | M7P27195AG | 2 | |
| sennosides a and b | ACTIVE MOIETY | 1B5FPI42EN | 2 |
Products#
Every source-derived product name is available through these pages.
- SENEXON-S
- DOCUSATE SODIUM -SENNOSIDES
- docusate sodium
- docusate
- sennosides a and b
- CARNAUBA WAX
- COLLOIDAL SILICON DIOXIDE
- CROSCARMELLOSE SODIUM
- D&C YELLOW NO. 10
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- FD&C YELLOW NO. 6
- HYPROMELLOSE 2910 (6 MPA.S)
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- POLYETHYLENE GLYCOL
- SODIUM BENZOATE
- STEARIC ACID
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 52959-675 | 52959-675-30, 52959-675-60, 52959-675-00, 52959-675-02, 52959-675-08 |
| 0536-4086 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e57a4e72-fd3d-44fa-96ca-06ea1d477cc8 | f6e923e8-46e8-4287-bd62-5b954829cd73 | 2011-12-29 | Warnings | e57a4e72-fd3d-44fa-96ca-06ea1d477cc8 f6e923e8-46e8-4287-bd62-5b954829cd73 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
